BAM
NEO icon

Blueshift Asset Management’s NeoGenomics NEO Stock Holding History

Blueshift Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,480
Closed -$115K – 687
2026
Q1 		$115K Buy
+15,480
New +$163K 0.03% 472
2019
Q3 		– Sell
-16,734
Closed -$367K – 875
2019
Q2 		$367K Buy
+16,734
New +$367K 0.05% 477
2019
Q1 		– Sell
-33,109
Closed -$418K – 860
2018
Q4 		$418K Buy
+33,109
New +$493K 0.08% 396

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Blueshift Asset Management's NEO Position: Q2 2026 in Review

Blueshift Asset Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 15,480 shares — an estimated $115K sold.

Blueshift Asset Management first reported a position in NEO in Q4 2018 and held it in 3 quarters. The position peaked at $418K in Q4 2018. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Blueshift Asset Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Blueshift Asset Management sold 15,480 NeoGenomics shares in Q2 2026, an estimated $115K.
  • Blueshift Asset Management first reported a position in NeoGenomics in Q4 2018 and held it in 3 quarters.
  • Blueshift Asset Management's NeoGenomics position peaked at $418K in Q4 2018.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.